Conformational regulation of integrin structure and function

Annual Review of Biophysics and Biomolecular Structure

Volumn 31, Issue , 2002, Pages 485-516

  Shimaoka, Motomu ^a   Takagi, Junichi ^a   Springer, Timothy A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Affinity regulation; Conformational change; Divalent cations; I domain; Signal transmission

Indexed keywords

EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; MAGNESIUM ION;

ALPHA HELIX; BETA PROPELLER; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONFORMATIONAL TRANSITION; HUMAN; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CATIONS; CELL ADHESION; INTEGRINS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036089390     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.31.101101.140922     Document Type: Review

References (105)

1. Cation binding to the integrin CD11b I domain and activation model assessment
2. Are changes in integrin affinity and conformation overemphasized?
3. 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium
4. Cysteine-rich structure reveals a fulcrum for integrin rearrangement upon activation
5. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
6. Exposure of platelet fibrinogen receptors by ADP and epinephrine
7. Cloning and expression of the chicken CD18 cDNA
8. Domains in plexins: Links to integrins and transcription factors
9. Functional consequences of integrin gene mutations in mice
10. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the β-subunits of the integrin family
11. Ribbons
12. A dimeric crystal structure for the N-terminal two domains of ICAM-1
13. Von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule
14. Chemokines trigger immediate β2 integrin affinity and mobility changes: Differential regulation and roles in lymphocyte arrest under flow
15. De Novo protein design: Fully automated sequence selection
16. Crystal structure of a tandem pair of fibronectin type III domains from the cytomplasmic tail of integrin α6β4
17. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands
18. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen
19. The dynamic regulation of integrin adhesiveness
20. 3
21. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity
22. T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1
23. Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte function-associated antigen-1
24. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib
25. Crystal structure of the I domain from integrin α2β1
26. Structural basis of collagen recognition by integrin α2β1
27. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: Two mechanisms with divergent biological consequences
28. Integrin signaling
29. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
30. IIbβ3
31. 2 subunit requires association with the α subunit
32. A binding interface on the I domain of lymphocyte function associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1)
33. 2 subunit
34. Structural and functional studies with antibodies to the integrin β2 subunit: A model for the I-like domain
35. Breaking the integrin hinge
36. Integrin structure
37. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding
38. Integrins: Versatility, modulation, and signaling in cell adhesion
39. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain
40. Amino acid residues in the αIIb subunit that are critical for ligand binding to integrin αIIbβ3 are clustered in the β-propeller model
41. Critical threonine and aspartic acid residues within the I domains of β2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi
42. Cutting edge: A small molecule antagonist of LFA-1-mediated cell adhesion
43. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-1 in hydrodynamic flow
44. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations
45. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: Evidence for the allosteric inhibition of a protein-protein interaction
46. Differential dynamics of α5 integrin, paxillin, and α-actinin during formation and disassembly of adhesions in migrating cells
47. Two conformations of the integrin A-domain (I-domain): A pathway for activation?
48. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/CD18)
49. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1
50. Effects of I domain deletion on the function of the β2 integrin lymphocyte function-associated antigen-1
51. 2+-complexed crystal structures
52. The integrin I domain: Crystals, metals and related artefacts
53. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. II. Mechanism of inhibition and structure-based improvement of pharmaceutical properties
54. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. I. Identification of an additional binding pocket based on an anilino diaryl sulfide lead
55. Integrin mediated cell adhesion: The extracellular face
56. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells
57. Epitope mapping of antibodies to the C-terminal region of the integrin β2 subunit reveals regions that become exposed upon receptor activation
58. The structure of the β-propeller domain and C-terminal region of the integrin αM subunit
59. An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide
60. Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains
61. Association of the membrane-proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state
62. Activation induced conformational changes in the I domain region of LFA-1
63. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD1 lb/CD18) is essential for ligand binding
64. Molecular switch for signal transduction: Structural differences between active and inactive forms of protooncogenic ras proteins
65. Getting integrins into shape: Recent insights into how integrin activity is regulated by conformational changes
66. 1 integrin chain
67. Crystal structure of the α1β1 integrin I-domain: Insights into integrin I-domain function
68. 2+-dependent binding of collagen by the integrin α2β1 in human platelets
69. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain
70. Experimental support for a β-propeller domain in integrin α-subunits and a calcium binding site on its lower surface
71. Green fluorescent protein (GFP) tagged to the cytoplasmic tail of αllb or β3 allows the expression of a fully functional integrin αIIbβ3: Effect of β3GFP on αIIbβ3 ligand binding
72. Evolution of domain families
73. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin αIIbβ3
74. Lβ2) integrin
75. The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin
76. 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1
77. Trench-shaped binding sites promote multiple classes of interactions between collagen and the adherence receptors, α1β1 integrin and Staphylococcus aureus Cna MSCRAMM
78. Comparative protein modelling by satisfaction of spatial restraints
79. Structure/function analysis of the integrin β1 subunit by epitope mapping
80. Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin αL I domains with high affinity and antagonist activity in vivo
81. Computational design of an integrin I domain stabilized in the open, high affinity conformation
82. A mechanism for divalent cation regulation of β3-integrins
83. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multi-step paradigm
84. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain
85. 2+-binding β-hairpin loop better resembles integrin sequence motifs than the EF-hand
86. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus
87. KIM127, an antibody that promotes adhesion, maps to a region of CD18 that includes cysteine-rich repeats
88. Regulation of leukocyte integrin function: Affinity vs. avidity
89. Structural basis of integrin-mediated signal transduction
90. Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin β subunits
91. C-terminal opening mimics "inside-out" activation of integrin α5β1
92. Defining the repeating elements in the cysteine-rich region (CRR) of the CD18 integrin β2 subunit
93. The "ligand-induced conformational change" of α5β1 integrin
94. The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes
95. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy
96. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
97. A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function
98. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain
99. Crystal structure of the extracellular segment of integrin αVβ3
100. Folding and function of I-domain deleted Mac-1 and LFA-1
101. 7 subunit
102. The top of the I-like domain of the integrin LFA-1 β subunit contacts the ot subunit β-propeller domain near β-sheet 3
103. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin β2 subunit that restrain activation of the integrin αXβ2
104. A discrete site modulates activation of I domains